Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
-
André P. van Rossum
Abstract
Background: Plasma vitamin B12 [cobalamin (Cbl)] concentrations are usually measured as a screening marker for vitamin B12 deficiency. Siemens Healthcare Diagnostics has introduced Cbl assays for various platforms, i.e., the immulite (IML) 2000 and 2500. In our laboratories, regular validation studies for the IML 2500 were conducted and showed acceptable quality specifications. After the introduction of the IML 2500 Cbl assay, clinicians in the department of internal medicine reported an increased frequency of patients with Cbl-concentrations less than 148 pmol/L.
Methods: In order to investigate this claim from the clinicians, we retrospectively analyzed the internal and external quality control (QC) of the Cbl assay. In addition, the monthly patient means for the Cbl assay were analyzed both before and after the introduction of the new Cbl assay.
Results: No abnormalities were found in the internal and external QCs. However, the monthly patient means for the Cbl assay showed a statistically significant decrease in cobalamin concentrations. Siemens acknowledged the problems and formulated a new Cbl assay, which was subsequently validated in our laboratories and showed equivocal Cbl results when compared to the IML 2000 Cbl assay.
Conclusions: We report a flawed validation study conducted by the manufacturer that resulted in an undetected analytical problem in the IML 2500 Cbl assay, its subsequent introduction on the market, the final recognition of the poor performance of the assay by our clinicians, and the eventual resolution by the manufacturer. Hence, it emphasizes the utmost importance for thorough comparison between assays over the entire measurement range, even when both assays are produced by the same manufacturer.
©2011 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
Articles in the same Issue
- Publisher's Note
- Publisher's Note
- Editorials
- Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
- Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
- Pharmacogenomics of alcohol metabolism: implications for legal testing
- Reviews
- Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
- Application of proteomics to prenatal screening and diagnosis for aneuploidies
- Opinion Paper
- Harmonization of free thyroid hormone tests: a mission impossible?
- Genetics and Molecular Diagnostics
- A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
- Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
- General Clinical Chemistry and Laboratory Medicine
- Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
- Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
- A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
- Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
- Interlaboratory study of free monoclonal immunoglobulin light chain quantification
- Serum zinc-α2-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
- Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
- Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
- Prevalence and course of pseudothrombocytopenia in outpatients
- Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
- Validation and Outcome Studies Reference Values and Biological Variations
- Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
- Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
- Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
- Cancer Diagnostics
- Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
- Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
- Letters to the Editor
- Factors reducing hemolysis rates in blood samples from the emergency department
- Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
- Crystal-associated pseudoeosinophilia of synovial fluid
